vs

Side-by-side financial comparison of Roivant Sciences Ltd. (ROIV) and SMITH MICRO SOFTWARE, INC. (SMSI). Click either name above to swap in a different company.

SMITH MICRO SOFTWARE, INC. is the larger business by last-quarter revenue ($4.0M vs $2.0M, roughly 2.0× Roivant Sciences Ltd.). On growth, SMITH MICRO SOFTWARE, INC. posted the faster year-over-year revenue change (-20.0% vs -77.8%). Over the past eight quarters, SMITH MICRO SOFTWARE, INC.'s revenue compounded faster (-17.2% CAGR vs -73.7%).

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Smith Micro Software, Inc., founded in 1982 by William W. Smith, Jr., is a developer and marketer of both enterprise and consumer-level software and services. Headquartered in Pittsburgh, Pennsylvania, Smith Micro maintains multiple domestic and international offices. United States locations include Aliso Viejo, California, and Pittsburgh, Pennsylvania. International offices are located throughout Europe and Asia. Currently, the company focuses on digital lifestyle solutions and security tech...

ROIV vs SMSI — Head-to-Head

Bigger by revenue
SMSI
SMSI
2.0× larger
SMSI
$4.0M
$2.0M
ROIV
Growing faster (revenue YoY)
SMSI
SMSI
+57.8% gap
SMSI
-20.0%
-77.8%
ROIV
Faster 2-yr revenue CAGR
SMSI
SMSI
Annualised
SMSI
-17.2%
-73.7%
ROIV

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ROIV
ROIV
SMSI
SMSI
Revenue
$2.0M
$4.0M
Net Profit
$-265.9M
Gross Margin
76.4%
Operating Margin
-16966.1%
-109.8%
Net Margin
-13301.2%
Revenue YoY
-77.8%
-20.0%
Net Profit YoY
-257.0%
EPS (diluted)
$-0.38
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ROIV
ROIV
SMSI
SMSI
Q4 25
$2.0M
$4.0M
Q3 25
$1.6M
$4.3M
Q2 25
$2.2M
$4.4M
Q1 25
$-39.6M
$4.6M
Q4 24
$9.0M
$5.0M
Q3 24
$4.5M
$4.6M
Q2 24
$8.0M
$5.1M
Q1 24
$28.9M
$5.8M
Net Profit
ROIV
ROIV
SMSI
SMSI
Q4 25
$-265.9M
Q3 25
$-113.5M
$-4.5M
Q2 25
$-223.4M
$-15.1M
Q1 25
$-206.5M
$-5.2M
Q4 24
$169.4M
Q3 24
$-230.2M
$-6.4M
Q2 24
$95.3M
$-6.9M
Q1 24
$-151.1M
$-31.0M
Gross Margin
ROIV
ROIV
SMSI
SMSI
Q4 25
76.4%
Q3 25
73.9%
Q2 25
73.5%
Q1 25
72.8%
Q4 24
75.6%
Q3 24
71.6%
Q2 24
68.7%
Q1 24
65.7%
Operating Margin
ROIV
ROIV
SMSI
SMSI
Q4 25
-16966.1%
-109.8%
Q3 25
-19492.9%
-103.2%
Q2 25
-13130.0%
-338.3%
Q1 25
674.8%
-112.7%
Q4 24
-3042.6%
-89.7%
Q3 24
-7636.0%
-140.0%
Q2 24
-1279.5%
-135.8%
Q1 24
-919.5%
-542.4%
Net Margin
ROIV
ROIV
SMSI
SMSI
Q4 25
-13301.2%
Q3 25
-7225.9%
-104.3%
Q2 25
-10292.9%
-340.8%
Q1 25
521.8%
-112.1%
Q4 24
1878.3%
Q3 24
-5143.8%
-137.0%
Q2 24
1192.7%
-134.8%
Q1 24
-522.3%
-534.8%
EPS (diluted)
ROIV
ROIV
SMSI
SMSI
Q4 25
$-0.38
$-0.15
Q3 25
$-0.17
$-0.25
Q2 25
$-0.33
$-0.78
Q1 25
$-0.28
$-0.28
Q4 24
$0.23
$0.54
Q3 24
$-0.31
$-0.54
Q2 24
$0.12
$-0.66
Q1 24
$-0.02
$-3.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ROIV
ROIV
SMSI
SMSI
Cash + ST InvestmentsLiquidity on hand
$4.5B
$1.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.3B
$18.4M
Total Assets
$5.2B
$25.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ROIV
ROIV
SMSI
SMSI
Q4 25
$4.5B
$1.5M
Q3 25
$4.4B
$1.4M
Q2 25
$4.5B
$1.4M
Q1 25
$4.9B
$2.3M
Q4 24
$5.1B
$2.8M
Q3 24
$5.4B
$1.5M
Q2 24
$5.7B
$5.6M
Q1 24
$6.5B
$6.2M
Total Debt
ROIV
ROIV
SMSI
SMSI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
ROIV
ROIV
SMSI
SMSI
Q4 25
$4.3B
$18.4M
Q3 25
$4.4B
$19.9M
Q2 25
$4.3B
$22.4M
Q1 25
$4.7B
$36.6M
Q4 24
$5.2B
$40.8M
Q3 24
$5.2B
$37.7M
Q2 24
$5.4B
$42.9M
Q1 24
$6.0B
$45.4M
Total Assets
ROIV
ROIV
SMSI
SMSI
Q4 25
$5.2B
$25.0M
Q3 25
$5.1B
$27.1M
Q2 25
$5.0B
$29.6M
Q1 25
$5.4B
$43.4M
Q4 24
$5.8B
$48.0M
Q3 24
$6.2B
$46.2M
Q2 24
$6.5B
$53.0M
Q1 24
$7.2B
$55.4M
Debt / Equity
ROIV
ROIV
SMSI
SMSI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ROIV
ROIV
SMSI
SMSI
Operating Cash FlowLast quarter
$-196.5M
$-2.2M
Free Cash FlowOCF − Capex
$-201.4M
FCF MarginFCF / Revenue
-10076.0%
Capex IntensityCapex / Revenue
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ROIV
ROIV
SMSI
SMSI
Q4 25
$-196.5M
$-2.2M
Q3 25
$-185.7M
$-2.1M
Q2 25
$-204.4M
$-2.3M
Q1 25
$-172.6M
$-602.0K
Q4 24
$-207.3M
$-4.9M
Q3 24
$-266.8M
$-3.8M
Q2 24
$-192.8M
$-4.2M
Q1 24
$-108.5M
$-1.3M
Free Cash Flow
ROIV
ROIV
SMSI
SMSI
Q4 25
$-201.4M
Q3 25
$-193.5M
$-2.2M
Q2 25
$-208.4M
Q1 25
$-173.4M
$-606.0K
Q4 24
$-209.1M
$-4.9M
Q3 24
$-267.8M
$-3.8M
Q2 24
$-193.8M
$-4.2M
Q1 24
$-108.8M
$-1.3M
FCF Margin
ROIV
ROIV
SMSI
SMSI
Q4 25
-10076.0%
Q3 25
-12317.8%
-49.6%
Q2 25
-9604.5%
Q1 25
438.1%
-13.1%
Q4 24
-2318.5%
-99.2%
Q3 24
-5984.4%
-82.2%
Q2 24
-2425.5%
-82.0%
Q1 24
-376.1%
-23.3%
Capex Intensity
ROIV
ROIV
SMSI
SMSI
Q4 25
246.9%
Q3 25
499.6%
0.5%
Q2 25
185.9%
Q1 25
-2.0%
0.1%
Q4 24
20.3%
0.1%
Q3 24
22.3%
0.1%
Q2 24
12.1%
0.1%
Q1 24
1.2%
0.1%
Cash Conversion
ROIV
ROIV
SMSI
SMSI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ROIV
ROIV

Segment breakdown not available.

SMSI
SMSI

Family Safety$3.2M80%
Other$797.0K20%

Related Comparisons